Pharmacodynamic/Pharmacokinetic Interactions Between Oral Roflumilast and Inhaled Formoterol
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Roflumilast
Related studies linked through entity extraction aliases.
Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease. Ratio-Study. (BY217/M2-112)
- Status
- COMPLETED
- Phase
- PHASE3
Effect of Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Tiotropium: The HELIOS Study (BY217/M2-128)
- Status
- COMPLETED
- Phase
- PHASE3
Effect of Roflumilast on Lung Function in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Salmeterol: The EOS Study (BY217/M2-127)
- Status
- COMPLETED
- Phase
- PHASE3
Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The HERMES Study (BY217/M2-125)
- Status
- COMPLETED
- Phase
- PHASE3
Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The AURA Study (BY217/M2-124)
- Status
- COMPLETED
- Phase
- PHASE3
Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-08)
- Status
- COMPLETED
- Phase
- PHASE3
Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 71 y) (APTA-2217-07)
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Oral Roflumilast Taken Once Daily in Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (BY217/M2-119)
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 70 y) (APTA-2217-05)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Efficacy and Safety of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-06)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Efficacy and Safety of Oral Roflumilast Taken With Low Dose Inhaled Corticosteroids in Patients With Asthma (12 to 70 y) (BY217/M2-013)
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Roflumilast Taken in the Morning or Evening in Patients With Stable Asthma (12 to 70 y) (BY217/M2-015)
- Status
- COMPLETED
- Phase
- PHASE3
The HERO-study: Effects of Roflumilast in Patients With COPD (Chronic Obstructive Pulmonary Disease) (BY217/M2-121)
- Status
- COMPLETED
- Phase
- PHASE3
OPUS Study: Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (BY217/M2-111)
- Status
- COMPLETED
- Phase
- PHASE3
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Roflumilast in Patients With Asthma (BY217/M2-012)
- Status
- COMPLETED
- Phase
- PHASE3
Effect of Roflumilast on Pulmonary Function and Respiratory Symptoms in Patients With Chronic Obstructive Pulmonary Disease (COPD) (BY217/M2-110)
- Status
- COMPLETED
- Phase
- PHASE3